HTRS Mid-Career Research Award
2020 HTRS MCRA (MCRA) Program: Deadline has passed
Letters of Intent were due Friday, March 20, 2020. Please see the 2020 Request for Proposals (RFP) for eligiblity requirements and submission guidelines that may be substantially similar next grant cycle. Questions should be directed to Dr. Terri Holzen in the HTRS office at [email protected] or by calling (414) 937-6569.
The HTRS Mid-Career Research Award (MCRA) Program provides financial support for mid-career investigators pursuing clinical, translational, or basic science research projects in hemostasis and/or thrombosis. Applicants must be working in the United States or Canada for the duration of the proposed project. The project funded by this year's program will run for two years: November 2020 - October 2022. The 2020 HTRS MCRA Program is supported by a grant to HTRS from Genentech.
The goals of the MCRA Program are to:
- Advance the science underlying the clinical management of hemostasis and thrombosis by supporting investigator-initiated research to ultimately improve the health and well-being of people living with blood disorders
- Provide financial support for talented mid-career physician-scientists to enable them to transition from mentored research to full research independence
- Combat the shortage of skilled academic researchers in benign hematology by supporting mid-career physician-scientists in the U.S. and Canada at a critical juncture in their academic research careers. Upon the completion of a project funded by the MCRA Program, the recipient should be ready to apply for a large-scale grant to expand their research in hemostasis and/or thrombosis such as an NIH R01, NIH R34, or the equivalent from another agency such as the Canadian Institutes of Health Research (CIHR)
Eligible investigators must be:
- Mid-career physician-scientists (MD, MD/PhD, or DO)
- Mid-career PhD researchers proposing collaborative projects with at least one other eligible mid-career physician-scientist
“Mid-career physician-scientists” are defined by HTRS as being at least five years (but not more than 15 years) out of fellowship as of the deadline of the Letter of Intent. A mid-career PhD researcher must be at least five years (but not more than 15 years) out of post-doctoral fellowships as of the deadline of the Letter of Intent, and must be working with at least one other eligible mid-career physician-scientist.
All applicants must be employed at academic research institutions (applicants working for commercial research laboratories are not eligible to apply).
For more information:
Request for Proposals
2019 HTRS Mid-Career Research Award (MCRA) Recipient
Jill M. Johnsen, MD
The 2019 MCRA was supported by an educational grant from Genentech.
2017 HTRS MCRA Recipient
Shannon L. Meeks, MD
The 2017 MCRA was supported by the Hemostasis and Thrombosis Research Society.